Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model

Table 2 Results of calibration process for main model estimations

	Model estimated	Reported	Reference
Prevalence of oncogenic HPV infections	9.7%	9.1% (15–69 years)	[10, 36]
Prevalence of low risk HPV infections	3.1%	3.7% (15–69 years)	[36]
Incident cases of genital warts	4813	4685	[35]
Incident cases of cervical cancer	1370	1331	[35]
Incident cases of deaths associated with cervical cancer	722	759	[35]

ISSN: 1471-2458